Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis

Osteoarthritis and Cartilage

Volumn 16, Issue 12, 2008, Pages 1494-1500

  Nemirovskiy, O V ^a   Sunyer, T ^a   Aggarwal, P ^a   Abrams, M ^a   Hellio Le Graverand, M P ^a   Mathews, W R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Biomarkers; Procollagen type II

Indexed keywords

ALLYSINE; COLLAGEN TYPE 2; GALACTOSE; GLUCOSE; HYDROXYLYSINE; LYSINE; PROCOLLAGEN; PROCOLLAGEN TYPE 2; PROLINE; UNCLASSIFIED DRUG;

AGED; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; BLOOD ANALYSIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; OSTEOARTHRITIS; OXIDATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SYNOVIAL FLUID; URINALYSIS;

ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CHROMATOGRAPHY, LIQUID; COLLAGEN TYPE II; DISEASE PROGRESSION; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; OSTEOARTHRITIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; RATS;

EID: 55349115077     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.04.021     Document Type: Article

References (23)

1. Greenspan D.S. Biosynthetic processing of collagen molecules. Top Curr Chem 247 (2005) 149-183
2. Lark M.W., Bayne E.K., Flanagan J., Harper C.F., Hoerrner L.A., Hutchinson N.I., et al. Aggrecan degradation in human cartilage. Evidence for both aggrecanase and matrix metalloproteinase activity in normal, osteoarthritic and rheumatoid joints. J Clin Invest 100 (1997) 93-106
3. Rizkalla G., Reiner A., Bogoch E., and Poole A.R. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90 (1992) 2268-2277
4. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 99 (1997) 1534-1545
5. Wu W., Billinghurst R.C., Pidoux I., Antoniou J., Zukor D., Tanzer M., et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 46 (2002) 2087-2094
6. Nelson F., Dahlberg L., Laverty S., Reiner A., Pidoux I., Ionescu M., et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102 (1998) 2115-2125
7. Sugiyama S., Itokazu M., Suzuki Y., and Shimizu K. Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 62 (2003) 27-32
8. Kobayashi H., Saito T., and Koshino T. Immunolocalization of carboxy-terminal type II procollagen peptide in regenerated articular cartilage of osteoarthritic knees after reduction of mechanical stress. Osteoarthritis Cartilage 10 (2002) 870-878
9. Shinmei M., Ito K., Matsuyama S., Yoshihara Y., and Matsuzawa K. Joint fluid carboxy-terminal type II procollagen peptide as marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1 (1993) 121-128
10. Lohmander L.S., Yoshihara Y., Roos H., Kobayashi T., Yamada H., and Shinmei M. Procollagen C-propeptide in joint fluid. Changes in concentrations with age, time after joint injury and osteoarthritis. J Rheumatol 23 (1996) 1765-1769
11. Aigner T., Zhu Y., Chonsky H.H., Matsen III F.A., Maloney W.J., and Sandell L.J. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 42 (1999) 1443-1450
12. Rousseau J.C., Zhu Y., Miossec P., Vignon E., Sandell L.J., Garnero P., et al. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 12 (Jun 2004) 440-447
13. Garnero P., Ayral X., Rousseau J.C., Christgau S., Sandell L.J., Dougados M., et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46 (2002) 2613-2624
14. Sharif M., Kirwan J., Charni N., Sandell L.J., Whittles C., and Garnero P. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis - association with disease progression. Rheumatology 46 (2007) 938-943
15. Olsen K., Sondergaard B.C., Byrjalsen I., Tanko L.B., Christiansen C., Muller A., et al. Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen. Osteoarthritis Cartilage 15 (2007) 335-342
16. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., and Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60 (2001) 619-626
17. Ishikawa T., Nishigaki F., Christgau S., Noto T., Mo J., From N., et al. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments. J Rheumatol 31 (2004) 1174-1179
18. Lohmander L.S., Atley L.M., Pietka T.A., and Eyre D.R. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 48 (2003) 3130-3139
19. Nemirovskiy O.V., Dufield D.R., Sunyer T., Aggarwal P., Welsch D.J., and Mathews W.R. Discovery and development of a type II collagen neoepitope (TIINE) biomarker for MMP activity: from in-vitro to in-vivo. Anal Biochem 391 (2007) 93-101
20. Downs J.T., Lane C.L., Nestor N.B., McLellan T.J., Kelly M.A., Karam G.A., et al. Analysis of collagenase-cleavage of type II collagen using a 1neoepitope ELISA. J Immunol Methods 247 (2001) 25-34
21. Charni N., Juillet F., and Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 52 (2005) 1081-1090
22. Fukui N., McAlinden A., Zhu Y., Crouch E., Broekelmann T.J., Mecham R.P., et al. Processing of type II procollagen amino propeptide by matrix metalloproteinases. J Biol Chem 277 (2002) 2193-2201
23. Van Den Steen P.E., Proost P., Grillet B., Brand D.D., Kang A.H., Van Damme J., et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16 (2002) 379-389